T
ISSUER//CIK 0001693415
Translate Bio, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13D/A181.5 KBTranslate Bio, Inc.Sep 16, 5:26 PM ET·0001567619-21-017202
- 8-K279.3 KBTranslate Bio, Inc.Sep 14, 10:12 AM ET·0001193125-21-272462
- SC 13G/A8.5 KBTranslate Bio, Inc.Sep 10, 9:33 AM ET·0000315066-21-001728
- SC 13D103.5 KBTranslate Bio, Inc.Aug 16, 12:38 PM ET·0001104659-21-105983
- SC 13D98.7 KBTranslate Bio, Inc.Aug 12, 4:00 PM ET·0001140361-21-028092
- 10-Q7.3 MBTranslate Bio, Inc.Aug 5, 5:06 PM ET·0001193125-21-237889
- SC 13D/A181.9 KBTranslate Bio, Inc.Aug 4, 4:17 PM ET·0001567619-21-014410
- 8-K938.2 KBTranslate Bio, Inc.Aug 3, 8:03 AM ET·0001193125-21-234062
- 8-K156.7 KBTranslate Bio, Inc.Jun 16, 4:48 PM ET·0001193125-21-192180
- SC 13G/A8.5 KBTranslate Bio, Inc.May 10, 1:11 PM ET·0000315066-21-001540
Insiders
10- Atlas Venture Associates VIII, Inc.10% Owner
- Atlas Venture Associates VIII, L.P.10% Owner
- Atlas Venture Fund VIII, L.P.10% Owner
- Barbier AnnChief Medical Officer
- Baupost Group GP, L.L.C.10% Owner
- BAUPOST GROUP LLC/MA10% Owner
- Beckman DaniellaDirector
- Burgess Paul D.General Counsel and Secretary
- Cloghessy PaulaSee Remarks
- Demetri GeorgeDirector
Tickers
No tickers on record
Addresses
business
29 HARTWELL AVENUE
LEXINGTON, MA, 02421
mailing
29 HARTWELL AVENUE
LEXINGTON, MA, 02421
Former Names
- RaNA Therapeutics, Inc.2017-01-05